MEDONEFARMA
LETERMOVIR LIQUID
PRODUCT DESCRIPTION
Letermovir is an antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease.
CHEMICAL NAME
2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid.
Brand Names
Prevymis, Letermovir
Category
Antiviral (anti-infective)
DOSAGE FORM
Injection: 240mg/12mL (20mg/mL) solution for single-dose vial.
INDICATIONS
Letermovir is used alone or together with another medicine (eg, cyclosporine) to prevent cytomegalovirus (CMV) infection and disease in patients who have received an allogeneic hematopoietic stem cell (bone marrow) transplant or in patients who have received kidney transplant who have a high risk for getting CMV.
NDC CODE
00006-5003-01 and 00006-5004-01.
STORAGE & SHELF LIFE
- Shelf life: 3 years (36 months) Unopened
- Store at 20°C to 25°C (68°F to 77°F).
Anti-infectives
Can’t find what you are looking for?
Please call us. We would love to help.